[Solution]Scholarly Sickle cell

Please feel free to use applicable materials to develop the paper. • APA References 2010-2017 • Double- spaced • 1-inch margin • 12 Font Times…

Please feel free to use applicable materials to develop the paper.

• APA References 2010-2017
• Double- spaced
• 1-inch margin
• 12 Font Times New Roman
• 300 words per page

Chapter One: Introduction and Overview of the Problem ( 5 pages)
• Introduction to Chapter
• Background (problem and supporting information)
• Significance (why the problem needs addressing)
• Question Guiding Inquiry (PICO)
• Theoretical Framework
• Definition of terms
• Conclusion to Chapter
• The focus of my scholarly project will be to explore the impact of using Teach Back on sickle cell trait (SCT) education for male and female patients in a selected outpatient clinic. As an advanced practice nurse, I have been providing care to women since 1996. The clients are predominantly of African American origin. SCT is a common inherited carrier state found in many of these clients. Over the past twenty years, many of these findings were at the initial prenatal visit in which this screening test is required. A vast majority of these patients who tested positive for SCT had no idea what that meant. They also did not know the status of their partners. Many people living with SCT are unaware of their sickle cell status (Paulukonis, Eckman, Snyder, Hagar, Feuchtbaum & Zhou, 2016). If both partners are carriers of the SCT, there is a 25 % chance of having a child with sickle cell disease (SCD). It is essential to inform people about their sickle cell status and educate them about possible health problems to future children and counsel them about their reproductive considerations.
• Sickle cell disease (SCD) is an inherited red blood cell disorder. It is one of the most common genetic diseases in the United States (U.S). According to the Center for Disease Control (CDC) (2016), more than 70,000 people in the U.S have SCD, and more than two million carry the SCT gene that allows them to pass it on to their children. It is also estimated that millions of people worldwide are affected by SCD, (CDC 2016). In SCD, the red blood cells become hard and sticky and look like a C-shape called a “sickle.” This condition results in very painful joints and frequent hospitalizations when in crisis (CDC, 2016). SCT and SCD are common in people whose ancestors came from sub-Saharan Africa, Spanish-speaking areas in the Western Hemisphere, South America, the Caribbean, and Central America. People from Saudi Arabia, India, Mediterranean countries like Turkey, Greece, and Italy are also affected (CDC, 2010).
• Gaps and future direction: Studies shows that as many as 1.5% of babies born in the United States have SCT. Based on previous studies, there are no standardized methods or protocols for alerting families or healthcare providers to this information. Educating patients about the possible health disorder of SCD that might be associated with the condition of SCT is critical. Counseling them about the impact that this might have on the family’s future reproductive choices is also vital, (Ojodu, Hulihan, Pope & Grant, 2014).
• By including educational materials and offer to test for the persons who do not know their sickle cell status is a critical step. Providing genetic counseling at the same time that families are given positive SCT results, may decrease the occurrence thereby reducing the public health burden of SCD, (Ojodu, Hulihan, Pope & Grant, 2014).

• PICOT Question:
“What is the impact of using Teach Back on sickle cell trait education for male and female patients in a selected outpatient clinic over a 3 month period?”
•  
(P) Male and female patients with unknown sickle cell trait status in a selected outpatient clinic.
 
(I) Teach Back Model for Sickle cell trait education
 
(C) Did education as an intervention increase knowledge about sickle cell trait compared to traditional patient education without using Teach Back?
 
(O) Impact of Teach Back. Knowledge and education about Sickle cell trait.
 
(T) Within a 3 month period.

• References:
• CDC (2010). Facts | Sickle Cell Disease | NCBDDD | CDC
• https://www.cdc.gov/ncbddd/sicklecell/facts.html
• CDC (2016) .What you don’t know about Sickle Cell Disease. Learning the Truth about One of the Most Common Genetic Diseases.
• http://www.cdc.gov/ncbddd/sicklecell.
• Ojodu, J., Hulihan, M, .M, Pope, S., N., Grant, A., M., (2014) Incidence of sickle cell trait–United States, 2010. Centers for Disease Control and Prevention (CDC).
• https://www.ncbi.nlm.nih.gov/pubmed/25503918
• Paulukonis, S.T., Eckman, J.R., Snyder, A.B., Hagar, W., Feuchtbaum, L.B., Zhou, M., (2016). Sickle Cell Trait & Other Hemoglobinopathies & Diabetes (For Providers)
(U.S. Department of Health and Human Services) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

Make sure that references are American Journals date 2010 to 2017.

Assignment status: Solved by our experts

>>>Click here to get this paper written at the best price. 100% Custom, 0% plagiarism.<<<

Leave a Reply

Your email address will not be published. Required fields are marked *